FEB 02, 2021
Teprotumumab for Optic Neuropathy and Thyroid Eye Disease
ASOPRS 2020
02:46
Neuro-Ophthalmology/Orbit, Oculoplastics/Orbit, Optic Neuropathy , Thyroid Eye Disease
In this interview, Drs. Julian Perry and Catherine Hwang discuss the use of teprotumumab for optic neuropathy and thyroid eye disease. A recent case study involving 2 patients with TED and optic neuropathy showed that teprotumumab infusions led to improvements in optic neuropathy. More data will be needed to confirm these findings.
Relevant Financial Disclosures: None